Peter Hecht is the CEO of Cyclerion Therapeutics, a clinical-stage biopharmaceutical company focused on neuropsychiatric diseases.
Peter Hecht is the CEO of Cyclerion Therapeutics, a clinical-stage biopharmaceutical company focused on neuropsychiatric diseases. He is also a director and 10% owner of Cyclerion Therapeutics. Previously, he was appointed to the Board of Directors of Kallyope Inc. and is currently the CEO of Tisento Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library